DIAGNOS INC (ADK.CA) Stock Fundamental Analysis

TSX-V:ADK • CA2524423068

0.3 CAD
+0.02 (+5.26%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

Overall ADK gets a fundamental rating of 0 out of 10. We evaluated ADK against 9 industry peers in the Health Care Technology industry. Both the profitability and financial health of ADK have multiple concerns. ADK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ADK has reported negative net income.
  • In the past year ADK has reported a negative cash flow from operations.
  • ADK had negative earnings in each of the past 5 years.
  • ADK had a negative operating cash flow in each of the past 5 years.
ADK.CA Yearly Net Income VS EBIT VS OCF VS FCFADK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M

1.2 Ratios

  • ADK has a worse Return On Assets (-406.07%) than 88.89% of its industry peers.
Industry RankSector Rank
ROA -406.07%
ROE N/A
ROIC N/A
ROA(3y)-296.48%
ROA(5y)-232.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADK.CA Yearly ROA, ROE, ROICADK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K

1.3 Margins

  • ADK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADK.CA Yearly Profit, Operating, Gross MarginsADK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ADK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ADK has been increased compared to 1 year ago.
  • The number of shares outstanding for ADK has been increased compared to 5 years ago.
  • The debt/assets ratio for ADK has been reduced compared to a year ago.
ADK.CA Yearly Shares OutstandingADK.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ADK.CA Yearly Total Debt VS Total AssetsADK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

  • ADK has an Altman-Z score of -62.18. This is a bad value and indicates that ADK is not financially healthy and even has some risk of bankruptcy.
  • ADK has a worse Altman-Z score (-62.18) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -62.18
ROIC/WACCN/A
WACC8.79%
ADK.CA Yearly LT Debt VS Equity VS FCFADK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

2.3 Liquidity

  • A Current Ratio of 0.39 indicates that ADK may have some problems paying its short term obligations.
  • The Current ratio of ADK (0.39) is comparable to the rest of the industry.
  • A Quick Ratio of 0.39 indicates that ADK may have some problems paying its short term obligations.
  • ADK has a Quick ratio of 0.39. This is comparable to the rest of the industry: ADK outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
ADK.CA Yearly Current Assets VS Current LiabilitesADK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for ADK have decreased strongly by -10.34% in the last year.
  • Looking at the last year, ADK shows a very negative growth in Revenue. The Revenue has decreased by -48.53% in the last year.
  • Measured over the past years, ADK shows a very negative growth in Revenue. The Revenue has been decreasing by -20.72% on average per year.
EPS 1Y (TTM)-10.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.71%
Revenue 1Y (TTM)-48.53%
Revenue growth 3Y-38.15%
Revenue growth 5Y-20.72%
Sales Q2Q%-30.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADK.CA Yearly Revenue VS EstimatesADK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
ADK.CA Yearly EPS VS EstimatesADK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ADK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADK.CA Price Earnings VS Forward Price EarningsADK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADK.CA Per share dataADK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ADK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DIAGNOS INC

TSX-V:ADK (2/27/2026, 7:00:00 PM)

0.3

+0.02 (+5.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-02
Earnings (Next)03-04
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners4.12%
Ins Owner ChangeN/A
Market Cap36.12M
Revenue(TTM)79.00K
Net Income(TTM)-4.76M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 457.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -406.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-296.48%
ROA(5y)-232.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.83%
Cap/Sales 18.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -62.18
F-Score3
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)14.45%
Cap/Depr(5y)23.63%
Cap/Sales(3y)8.19%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.53%
Revenue growth 3Y-38.15%
Revenue growth 5Y-20.72%
Sales Q2Q%-30.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-57.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.62%
OCF growth 3YN/A
OCF growth 5YN/A

DIAGNOS INC / ADK.CA FAQ

Can you provide the ChartMill fundamental rating for DIAGNOS INC?

ChartMill assigns a fundamental rating of 0 / 10 to ADK.CA.


What is the valuation status of DIAGNOS INC (ADK.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to DIAGNOS INC (ADK.CA). This can be considered as Overvalued.


What is the profitability of ADK stock?

DIAGNOS INC (ADK.CA) has a profitability rating of 0 / 10.